Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013:2013:495319.
doi: 10.1155/2013/495319. Epub 2013 Oct 29.

Preparation and characterization of a gastric floating dosage form of capecitabine

Affiliations

Preparation and characterization of a gastric floating dosage form of capecitabine

Ehsan Taghizadeh Davoudi et al. Biomed Res Int. 2013.

Abstract

Gastrointestinal disturbances, such as nausea and vomiting, are considered amongst the main adverse effects associated with oral anticancer drugs due to their fast release in the gastrointestinal tract (GIT). Sustained release formulations with proper release profiles can overcome some side effects of conventional formulations. The current study was designed to prepare sustained release tablets of Capecitabine, which is approved by the Food and Drug Administration (FDA) for the treatment of advanced breast cancer, using hydroxypropyl methylcellulose (HPMC), carbomer934P, sodium alginate, and sodium bicarbonate. Tablets were prepared using the wet granulation method and characterized such that floating lag time, total floating time, hardness, friability, drug content, weight uniformity, and in vitro drug release were investigated. The sustained release tablets showed good hardness and passed the friability test. The tablets' floating lag time was determined to be 30-200 seconds, and it floated more than 24 hours and released the drug for 24 hours. Then, the stability test was done and compared with the initial samples. In conclusion, by adjusting the right ratios of the excipients including release-retarding gel-forming polymers like HPMC K4M, Na alginate, carbomer934P, and sodium bicarbonate, sustained release Capecitabine floating tablet was formulated.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Calibration curve of Capecitabine in HCL 0.1 N.
Figure 2
Figure 2
In vitro release profiles of various Capecitabine floating formulations in 0.1 N HCl (pH 1.2) at 37 ± 0.5°C (n = 4).
Figure 3
Figure 3
The influence of carbomer934P on the release of Capecitabine from the SR tablets in 0.1 N HCl (pH 1.2) at 37 ± 0.5°C (n = 4).
Figure 4
Figure 4
The influence of HPMC K4M in F4, F7, and F10 on the release of Capecitabine from the SR tablets in 0.1 N HCl (pH 1.2) at 37 ± 0.5°C (n = 4).
Figure 5
Figure 5
The influence of Na alginate in F4, F5, and F6 on the release of Capecitabine from the SR tablets in 0.1 N HCl (pH 1.2) at 37 ± 0.5°C (n = 4).
Figure 6
Figure 6
The influence of Na alginate in F7, F8, and F9 on the release of Capecitabine from the SR tablets in 0.1 N HCl (pH 1.2) at 37 ± 0.5°C (n = 4).
Figure 7
Figure 7
Release profiles of a commercial brand of Capecitabine and F7 (n = 4).
Figure 8
Figure 8
Comparison of the release profiles of F7 and stored tablets (n = 4).

References

    1. Cook JD, Carriaga M, Kahn SG, Schalch W, Skikne BS. Gastric delivery system for iron supplementation. The Lancet. 1990;335(8698):1136–1139. - PubMed
    1. Yoo GJ, Levine EG, Aviv C, Ewing C, Au A. Older women, breast cancer, and social support. Supportive Care in Cancer. 2010;18(12):1521–1530. - PMC - PubMed
    1. Miyazaki S, Yamaguchi H, Yokouchi C, Takada M, Hou W-M. Sustained-release and intragastric-floating granules of indomethacin using chitosan in rabbits. Chemical and Pharmaceutical Bulletin. 1988;36(10):4033–4038. - PubMed
    1. Leonard RCF, Pwint TP. Therapeutic aspect of metastatic breast cancer: chemotherapy. In: Mansel RE, editor. Metastasis of Breast Cancer. Berlin, Germany: Springer; 2007. pp. 373–388.
    1. Arora S, Ali J, Ahuja A, Khar RK, Baboota S. Floating drug delivery systems: a review. AAPS PharmSciTech. 2005;6(3):372–390. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources